Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C24H30Cl2O6 |
| Molecular Weight | 485.397 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 7 / 7 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOC(=O)[C@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)OC(=O)C(Cl)Cl
InChI
InChIKey=QAIOVDNCIZSSSF-RFAJLIJZSA-N
InChI=1S/C24H30Cl2O6/c1-4-31-21(30)24(32-20(29)19(25)26)10-8-16-15-6-5-13-11-14(27)7-9-22(13,2)18(15)17(28)12-23(16,24)3/h7,9,11,15-19,28H,4-6,8,10,12H2,1-3H3/t15-,16-,17-,18+,22-,23-,24-/m0/s1
| Molecular Formula | C24H30Cl2O6 |
| Molecular Weight | 485.397 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 7 / 7 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.google.us/patents/US5981517Curator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/12893841 | https://www.ncbi.nlm.nih.gov/pubmed/15212312 | http://adisinsight.springer.com/drugs/800016206
Sources: https://www.google.us/patents/US5981517
Curator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/12893841 | https://www.ncbi.nlm.nih.gov/pubmed/15212312 | http://adisinsight.springer.com/drugs/800016206
Etiprednol dicloacetate (BNP-166; ethyl-17alpha-dichloroacetoxy-11beta-hydroxyandrosta-1,4-diene-3-one-17beta-carboxylate) is a new soft steroid. The compound proved to be a dissociated glucocorticoid, showing a reduction in transactivating activity while preserving transrepressive abilities. The compound effectively decreased cytokine production in lipopolysaccharide-stimulated lymphocytes and attenuated lectin-induced proliferation of blood mononuclear cells in tissue culture. The significant local effect of the compound will very likely be accompanied by a drastically reduced systemic activity indicating an encouraging selectivity of the pharmacological action of etiprednol dicloacetate. Etiprednol dicloacetate had been in a clinical trial for the treatment of allergic rhinitis, asthma and Crohn's disease. However, development has been discontinued.
Originator
Sources: https://www.google.us/patents/US5981517
Curator's Comment: reference retrieved from https://www.ncbi.nlm.nih.gov/pubmed/12893841
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: GO:0006954 Sources: https://www.ncbi.nlm.nih.gov/pubmed/15212312 |
|||
Target ID: CHEMBL3368 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Corticosteroid design for the treatment of asthma: structural insights and the therapeutic potential of soft corticosteroids. | 2006 |
|
| Anti-inflammatory effect and soft properties of etiprednol dicloacetate (BNP-166), a new, anti-asthmatic steroid. | 2004-05 |
|
| Potency and specificity of the pharmacological action of a new, antiasthmatic, topically administered soft steroid, etiprednol dicloacetate (BNP-166). | 2003-10 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12893841
Sensitized rats were treated intratracheally with different doses (0.1, 1, 10, and 100 g/kg) of etiprednol dicloacetate and 2 h later were
challenged with ovalbumin aerosol.
Route of Administration:
Intratracheal
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15212312
Curator's Comment: Etiprednol dicloacetate effectively decreased cytokine production in lipopolysaccharide stimulated lymphocytes and attenuated lectin-induced proliferation of blood mononuclear cells in tissue culture.
Unknown
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:58:28 GMT 2025
by
admin
on
Mon Mar 31 17:58:28 GMT 2025
|
| Record UNII |
332VLD554F
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C521
Created by
admin on Mon Mar 31 17:58:28 GMT 2025 , Edited by admin on Mon Mar 31 17:58:28 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
OO-37
Created by
admin on Mon Mar 31 17:58:28 GMT 2025 , Edited by admin on Mon Mar 31 17:58:28 GMT 2025
|
PRIMARY | |||
|
199331-40-3
Created by
admin on Mon Mar 31 17:58:28 GMT 2025 , Edited by admin on Mon Mar 31 17:58:28 GMT 2025
|
PRIMARY | |||
|
C80816
Created by
admin on Mon Mar 31 17:58:28 GMT 2025 , Edited by admin on Mon Mar 31 17:58:28 GMT 2025
|
PRIMARY | |||
|
332VLD554F
Created by
admin on Mon Mar 31 17:58:28 GMT 2025 , Edited by admin on Mon Mar 31 17:58:28 GMT 2025
|
PRIMARY | |||
|
m1141
Created by
admin on Mon Mar 31 17:58:28 GMT 2025 , Edited by admin on Mon Mar 31 17:58:28 GMT 2025
|
PRIMARY | Merck Index | ||
|
8329
Created by
admin on Mon Mar 31 17:58:28 GMT 2025 , Edited by admin on Mon Mar 31 17:58:28 GMT 2025
|
PRIMARY | |||
|
CHEMBL2107614
Created by
admin on Mon Mar 31 17:58:28 GMT 2025 , Edited by admin on Mon Mar 31 17:58:28 GMT 2025
|
PRIMARY | |||
|
300000034134
Created by
admin on Mon Mar 31 17:58:28 GMT 2025 , Edited by admin on Mon Mar 31 17:58:28 GMT 2025
|
PRIMARY | |||
|
DTXSID401313806
Created by
admin on Mon Mar 31 17:58:28 GMT 2025 , Edited by admin on Mon Mar 31 17:58:28 GMT 2025
|
PRIMARY | |||
|
9935073
Created by
admin on Mon Mar 31 17:58:28 GMT 2025 , Edited by admin on Mon Mar 31 17:58:28 GMT 2025
|
PRIMARY | |||
|
3209
Created by
admin on Mon Mar 31 17:58:28 GMT 2025 , Edited by admin on Mon Mar 31 17:58:28 GMT 2025
|
PRIMARY | |||
|
DB05442
Created by
admin on Mon Mar 31 17:58:28 GMT 2025 , Edited by admin on Mon Mar 31 17:58:28 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
TARGET->INHIBITOR OF RELEASE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
METABOLITE INACTIVE -> PARENT |
MAJOR
PLASMA
|
||
|
METABOLITE INACTIVE -> PARENT |
ETIPREDNOL DICLOACETATE is a soft steroid hydrolysis occurs by an esterase.
MAJOR
PLASMA
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|